Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma
      QxMD      Google Scholar   
Citation:
JAMA Oncol vol 5 (11) 1582–8
Year:
2019
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
SDC:
No
Book Volume:
9
Parents:
2418   2912   2418  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
Bayer  
Grants:
U10CA180821, U10CA180882, U10CA077202, U10CA180820, U10CA180830, U10CA189859, U10CA180888, UG1CA189821  
Corr. Author:
 
Authors:
                                                       
Study
CALGB-80802
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: